Undifferentiated Carcinoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Cyclophosphamide for Nasopharyngeal Carcinoma
Conditions: Recurrent Nasopharyngeal Undifferentiated Carcinoma; Stage IV Nasopharyngeal Undifferentiated CarcinomaIntervention: Drug: CyclophosphamideSponsor: The University of Hong KongActive, not recruiting - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 30, 2016 Category: Research Source Type: clinical trials
